Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Equity Issued and Repurchased Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Genesis Energy (GEL) Asset Writedowns and Impairment (2020)

Genesis Energy's Asset Writedowns and Impairment history spans 1 years, with the latest figure at $3.3 million for Q3 2020.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $3.3 million in Q3 2020 year-over-year; TTM through Sep 2021 was $3.3 million, a 98.82% decrease, with the full-year FY2024 number at $43.0 million, changed N/A from a year prior.
Asset Writedowns and Impairment hit $3.3 million in Q3 2020 for Genesis Energy, down from $277.5 million in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for GEL hit a ceiling of $277.5 million in Q2 2020 and a floor of $3.3 million in Q3 2020.